Found: 16
Select item for more details and to access through your institution.
Rozerem.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 244
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 244
- Publication type:
- Article
Pipeline preview.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 244
- Publication type:
- Article
New molecular entities. Rozerem: ramelteon.
- Published in:
- 2005
- Publication type:
- Journal Article
Tigecycline: a novel glycylcycline antibiotic.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Tigecycline.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 245
- By:
- Publication type:
- Article
Drug use issues and actions. Non-elderly patients with overactive bladder have significant comorbidities.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Non-elderly patients with overactive bladder have significant comorbidities.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 255
- By:
- Publication type:
- Article
Policy watch. Crawford seeks to restore confidence in FDA approval process: drug safety and access top the priority list for new FDA commissioner.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Crawford seeks to restore confidence in FDA approval process.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 257
- By:
- Publication type:
- Article
The levothyroxine spectrum: bioequivalence and cost considerations.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
The levothyroxine spectrum: Bioequivalence and cost considerations.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 258
- By:
- Publication type:
- Article
news in brief.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 270
- Publication type:
- Article
Dual peroxisome proliferator-activated receptor agonist demonstrates significant lipid benefits.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 270
- Publication type:
- Article
News capsules. Dual peroxisome proliferator-activated receptor agonist demonstrates significant lipid benefits.
- Published in:
- 2005
- Publication type:
- Journal Article
Antipsychotic agents.
- Published in:
- Formulary, 2005, v. 40, n. 8, p. 272
- Publication type:
- Article